ABEC launches 6,000L single-use bioreactor to answer scalability needs
After breaking the 2,000L ‘ceiling’ of manufacturing capacity, ABEC launches a single-use bioreactor of 6,000L to answer clients’ scalability demands.
Archives for September 12, 2019
Grünenthal sets down over $1bn for off-the-shelf cell therapy
Grünenthal agrees deal with Mesoblast to develop and commercialize an allogeneic cell therapy for chronic lower back pain.